Hydrogen Protects Skin Cells from Damage in Vitiligo Research
- Authors
- Wei Fang, Luyan Tang, Guizhen Wang, Jinran Lin, Wanqing Liao, Weihua Pan, Jinhua Xu
- Journal
- Journal of Investigative Dermatology
- Year
- 2020
- DOI
- 10.1016/j.jid.2019.03.1165
- Study Type
- Cell Culture
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Vitiligo
- Body System
- Integumentary System
TL;DR
Molecular hydrogen (H2) may be a potential treatment for vitiligo by reducing oxidative stress and preventing cell damage in skin cells.
Key Finding
Molecular hydrogen reduced oxidative damage in human melanocytes and prevented cell death by activating Nrf2 signaling, with effects occurring in both normal cells and cells from vitiligo patients.
Summary
Researchers tested whether molecular hydrogen (H2) could protect skin cells called melanocytes from damage caused by oxidative stress (harmful chemical reactions in cells). Using cells grown in the laboratory, they found that H2 reduced harmful molecules in the cells, prevented cell death, and activated protective pathways—particularly one called Nrf2 signaling. These effects were observed in both normal melanocytes and those from people with vitiligo, a condition where skin loses pigment due to melanocyte damage.
Practical Takeaway
This laboratory study suggests H2 may have potential as a treatment for vitiligo by protecting melanocytes from oxidative stress. However, this is early-stage cell research only—it has not been tested in humans or animals yet, so it's far too early to know if these effects would translate to actual health benefits in people with vitiligo or other skin conditions.
Abstract
Oxidative stress is proven to be critical for the initiation and progression of vitiligo. Molecular hydrogen (H2) possesses potent antioxidant activity and has been shown to protect against various oxidative stress-related diseases. In this study, we first investigated the effects and mechanisms of H2 in human melanocytes damaged by hydrogen peroxide. We initially found that H2 reduced intracellular ROS accumulation and malondialdehyde levels in both vitiligo specimens and hydrogen peroxide-treated melanocytes in vitro in a concentration- and time-dependent manner, concomitant with the enhancement of antioxidant enzyme activity. Correspondingly, H2 reversed hydrogen peroxide-induced apoptosis and dysfunction in both normal and vitiligo melanocytes. H2 protected mitochondrial morphology and function in melanocytes under stress and promoted the activation of Nrf2 signaling, whereas Nrf2 deficiency abolished the protective effect of H2 against hydrogen peroxide-induced oxidative damage. Furthermore, H2 positively modulated β-catenin in hydrogen peroxide-treated melanocytes, and the β-catenin pathway was implicated in H2-induced Nrf2 activation. Collectively, our results indicate that H2 could be a promising therapeutic agent for vitiligo treatment via attenuating oxidative damage, and its beneficial effect in human melanocytes might involve Wnt/β-catenin-mediated activation of Nrf2 signaling.